Diversity and host range of Shiga toxin-encoding phage.

Shantini D Gamage, Angela K Patton, James F Hanson, Alison A Weiss
Author Information
  1. Shantini D Gamage: Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0524, USA.

Abstract

Shiga toxin 2 (Stx2) from the foodborne pathogen Escherichia coli O157:H7 is encoded on a temperate bacteriophage. Toxin-encoding phages from C600::933W and from six clinical E. coli O157:H7 isolates were characterized for PCR polymorphisms, phage morphology, toxin production, and lytic and lysogenic infection profiles on O157 and non-O157 serotype E. coli. The phages were found to be highly variable, and even phages isolated from strains with identical pulsed-field gel electrophoresis profiles differed. Examination of cross-plaquing and lysogeny profiles further substantiated that each phage is distinct; reciprocal patterns of susceptibility and resistance were not observed and it was not possible to define immunity groups. The interaction between Shiga toxin-encoding phage and intestinal E. coli was examined. Lytic infection was assessed by examining Shiga toxin production following overnight incubation with phage. While not common, lytic infection was observed, with a more-than-1,000-fold increase in Stx2 seen in one case, demonstrating that commensal E. coli cells can amplify Shiga toxin if they are susceptible to infection by the Shiga toxin-encoding phages. Antibiotic-resistant derivatives of the Stx2-encoding phages were used to examine lysogeny. Different phages were found to lysogenize different strains of intestinal E. coli. Lysogeny was found to occur more commonly than lytic infection. The presence of a diverse population of Shiga toxin-encoding phages may increase the pathogenic fitness of E. coli O157:H7.

References

  1. Infect Immun. 1999 Dec;67(12):6710-4 [PMID: 10569798]
  2. Lancet. 1999 May 8;353(9164):1588-9 [PMID: 10334263]
  3. Infect Immun. 2000 Mar;68(3):1116-24 [PMID: 10678915]
  4. N Engl J Med. 2000 Jun 29;342(26):1930-6 [PMID: 10874060]
  5. Infect Immun. 2000 Sep;68(9):4856-64 [PMID: 10948097]
  6. Emerg Infect Dis. 2000 Sep-Oct;6(5):458-65 [PMID: 10998375]
  7. Appl Environ Microbiol. 2000 Oct;66(10):4555-8 [PMID: 11010916]
  8. Nature. 2001 Jan 25;409(6819):529-33 [PMID: 11206551]
  9. Infect Immun. 2001 Mar;69(3):1934-7 [PMID: 11179378]
  10. J Bacteriol. 2001 Mar;183(6):2081-5 [PMID: 11222608]
  11. Microbiology. 2001 Jun;147(Pt 6):1671-6 [PMID: 11390698]
  12. Microbiology. 2001 Jul;147(Pt 7):1929-36 [PMID: 11429469]
  13. Appl Environ Microbiol. 2001 Sep;67(9):4335-7 [PMID: 11526041]
  14. Infect Immun. 2001 Dec;69(12):7588-95 [PMID: 11705937]
  15. J Clin Microbiol. 2002 Nov;40(11):3951-5 [PMID: 12409357]
  16. Infect Immun. 2003 Jun;71(6):3107-15 [PMID: 12761088]
  17. Infect Immun. 2003 Jun;71(6):3409-18 [PMID: 12761125]
  18. Infect Immun. 2003 Aug;71(8):4554-62 [PMID: 12874335]
  19. Mol Microbiol. 2004 Mar;51(6):1691-704 [PMID: 15009895]
  20. Virology. 1970 Mar;40(3):734-44 [PMID: 4908735]
  21. Nature. 1981 Nov 19;294(5838):217-23 [PMID: 6457992]
  22. J Bacteriol. 1984 Feb;157(2):690-3 [PMID: 6363394]
  23. Science. 1984 Nov 9;226(4675):694-6 [PMID: 6387911]
  24. J Infect Dis. 1989 Dec;160(6):994-8 [PMID: 2685131]
  25. Infect Immun. 1993 Feb;61(2):534-43 [PMID: 8423084]
  26. DNA Res. 1999 Aug 31;6(4):235-40 [PMID: 10492170]
  27. Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25 [PMID: 10511517]
  28. J Clin Microbiol. 1995 Sep;33(9):2233-9 [PMID: 7494007]
  29. Infect Immun. 1996 Feb;64(2):495-502 [PMID: 8550198]
  30. J Clin Microbiol. 1996 Feb;34(2):463-5 [PMID: 8789041]
  31. J Clin Microbiol. 1997 Nov;35(11):2977-80 [PMID: 9350772]
  32. Clin Microbiol Rev. 1998 Jan;11(1):142-201 [PMID: 9457432]
  33. J Bacteriol. 1998 Mar;180(5):1159-65 [PMID: 9495754]
  34. Infect Immun. 1998 Sep;66(9):4496-8 [PMID: 9712806]
  35. Gene. 1998 Nov 26;223(1-2):105-13 [PMID: 9858702]
  36. Infect Immun. 1999 Feb;67(2):546-53 [PMID: 9916057]
  37. J Clin Microbiol. 1999 Mar;37(3):497-503 [PMID: 9986802]
  38. J Bacteriol. 1999 Mar;181(6):1767-78 [PMID: 10074068]
  39. J Infect Dis. 2000 Feb;181(2):664-70 [PMID: 10669353]

Grants

  1. T32 AI055406/NIAID NIH HHS
  2. R21 AI 02008/NIAID NIH HHS
  3. T32 AI 055406/NIAID NIH HHS

MeSH Term

Bacteriophages
Blotting, Southern
Escherichia coli
Escherichia coli O157
Feces
Humans
Lysogeny
Shiga Toxin 2

Chemicals

Shiga Toxin 2

Word Cloud

Created with Highcharts 10.0.0ShigacoliphagesEphageinfectiontoxintoxin-encodingO157:H7lyticprofilesfoundStx2productionstrainslysogenyobservedintestinalincrease2foodbornepathogenEscherichiaencodedtemperatebacteriophageToxin-encodingC600::933WsixclinicalisolatescharacterizedPCRpolymorphismsmorphologylysogenicO157non-O157serotypehighlyvariableevenisolatedidenticalpulsed-fieldgelelectrophoresisdifferedExaminationcross-plaquingsubstantiateddistinctreciprocalpatternssusceptibilityresistancepossibledefineimmunitygroupsinteractionexaminedLyticassessedexaminingfollowingovernightincubationcommonmore-than-1000-foldseenonecasedemonstratingcommensalcellscanamplifysusceptibleAntibiotic-resistantderivativesStx2-encodingusedexamineDifferentlysogenizedifferentLysogenyoccurcommonlypresencediversepopulationmaypathogenicfitnessDiversityhostrange

Similar Articles

Cited By